Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,700 shares at $119.95 ($204K) on 2021-02-10, disclosed to the SEC on 2021-02-12.
Seasonal sale ($204k) by Chief Regulatory Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $119.95 | 600 | $72K | 35.3% |
| 2 | $119.96 | 1,100 | $132K | 64.7% |
| Total | $119.96 avg | 1,700 | $204K | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |